Publicação
Presentation Is Essential for Glycan-Lectin Recognition at the Molecular and Cellular Levels
| dc.contributor.author | Grosso, Ana Sofia | |
| dc.contributor.author | Diniz, Ana | |
| dc.contributor.author | Soares, Cátia O. | |
| dc.contributor.author | Goerdeler, Felix | |
| dc.contributor.author | Gimeno, Ana | |
| dc.contributor.author | Coelho, Pedro | |
| dc.contributor.author | Coelho, Helena | |
| dc.contributor.author | Lima, Carlos D.L. | |
| dc.contributor.author | Pinheiro, Benedita | |
| dc.contributor.author | Lete, Marta G. | |
| dc.contributor.author | Garcia-Martin, Fayna | |
| dc.contributor.author | Jaroentomeechai, Thapakorn | |
| dc.contributor.author | Gomes, Joana | |
| dc.contributor.author | Reis, Celso A. | |
| dc.contributor.author | Westerlind, Ulrika | |
| dc.contributor.author | Corzana, Francisco | |
| dc.contributor.author | Palma, Angelina S. | |
| dc.contributor.author | Clausen, Henrik | |
| dc.contributor.author | Jiménez-Barbero, Jesús | |
| dc.contributor.author | van Vliet, Sandra J. | |
| dc.contributor.author | Narimatsu, Yoshiki | |
| dc.contributor.author | Marcelo, Filipa | |
| dc.contributor.institution | UCIBIO - Applied Molecular Biosciences Unit | |
| dc.contributor.institution | DQ - Departamento de Química | |
| dc.contributor.pbl | ACS - American Chemical Society | |
| dc.date.accessioned | 2026-03-23T11:03:02Z | |
| dc.date.available | 2026-03-23T11:03:02Z | |
| dc.date.issued | 2025-12-29 | |
| dc.description | Publisher Copyright: © 2025 The Authors. Published by American Chemical Society | |
| dc.description.abstract | The human macrophage galactose-type lectin (MGL) recognizes exposed GalNAc residues abundantly found in tumor O-glycans. Herein, we have used an integrative chemical, structural, and functional approach to unravel the intricate specificity and molecular determinants that underlie the recognition of Thomsen-nouveau (Tn), the sialylated variant (STn), and Thomsen-Friedenreich (TF) O-glycans by the carbohydrate recognition domain of the MGL (MGL-CRD) at the molecular and cellular levels. The MGL-CRD prefers binding to Tn > STn ≫ TF O-glycans. In this molecular context, NMR, isothermal titration calorimetry, and molecular dynamics simulations revealed quantitative key structural and dynamic differences in binding, depending on the O-glycan. Interestingly, the density of Tn epitopes was critical for engaging multiple MGL-CRDs to MUC1 Tn-glycopeptides; however, the enthalpy–entropy balance strongly influenced the affinity, and a higher Tn density did not improve the binding. Cell-based mucin arrays recapitulated the MGL-CRD binding preference (Tn > STn ≫TF), but no preference for a specific O-glycan pattern in mucins was observed. The MGL-CRD also selectively recognizes glycoengineered gastric cancer cells expressing Tn/STn. Conversely, in the cellular context, employing CHO cells expressing the full-length MGL (CHO+MGL) allowed analysis of the MGL binding properties in its native presentation toward tagged isolated mucin reporters. Specificity for short tumor-associated O-glycans without any preference for a specific mucin was confirmed. Stunningly, the CHO+MGL cells revealed that the MGL shows similar binding to the STn and TF mucin reporters, suggesting that its natural oligomeric state displays promiscuous binding to simple O-glycans. Conceptually, the key role of glycan and lectin presentations for binding is thus highlighted. Moreover, this suggests the compelling scenario that the MGL serves as a universal receptor for truncated cancer-associated O-glycans. | en |
| dc.description.version | publishersversion | |
| dc.description.version | published | |
| dc.format.extent | 13 | |
| dc.format.extent | 8825096 | |
| dc.identifier.doi | 10.1021/jacsau.5c00905 | |
| dc.identifier.issn | 2691-3704 | |
| dc.identifier.other | PURE: 158207876 | |
| dc.identifier.other | PURE UUID: d6fc55ff-5310-48ff-b40b-51327e3686f5 | |
| dc.identifier.other | Scopus: 105028306402 | |
| dc.identifier.other | ORCID: /0000-0001-5797-6555/work/209454296 | |
| dc.identifier.other | ORCID: /0000-0001-5049-8511/work/209454532 | |
| dc.identifier.other | WOS: 001650824600001 | |
| dc.identifier.other | PubMed: 41614153 | |
| dc.identifier.other | PubMedCentral: PMC12848722 | |
| dc.identifier.uri | http://hdl.handle.net/10362/201731 | |
| dc.identifier.url | https://www.scopus.com/pages/publications/105028306402 | |
| dc.identifier.url | https://www.webofscience.com/wos/woscc/full-record/WOS:001650824600001 | |
| dc.language.iso | eng | |
| dc.peerreviewed | yes | |
| dc.subject | Glycan and receptor presentation | |
| dc.subject | Macrophage galactose-type lectin | |
| dc.subject | Molecular recognition | |
| dc.subject | Tumor-associatedO-glycans | |
| dc.subject | Analytical Chemistry | |
| dc.subject | Chemistry (miscellaneous) | |
| dc.subject | Physical and Theoretical Chemistry | |
| dc.subject | Organic Chemistry | |
| dc.subject | SDG 3 - Good Health and Well-being | |
| dc.title | Presentation Is Essential for Glycan-Lectin Recognition at the Molecular and Cellular Levels | en |
| dc.title.subtitle | The Interaction of Tumor-Associated O-Glycans with the Macrophage Galactose-Type Lectin | en |
| dc.type | journal article | |
| degois.publication.firstPage | 82 | |
| degois.publication.issue | 1 | |
| degois.publication.lastPage | 94 | |
| degois.publication.title | JACS Au | |
| degois.publication.volume | 6 | |
| dspace.entity.type | Publication | |
| rcaap.rights | openAccess |
Ficheiros
Principais
1 - 1 de 1
A carregar...
- Nome:
- Grosso_A._et_al_2025_.pdf
- Tamanho:
- 8.42 MB
- Formato:
- Adobe Portable Document Format
